Keyphrases
Ovarian Cancer
100%
Field Asymmetric Ion Mobility Spectrometry (FAIMS)
91%
Malignant Ovarian Tumor
60%
Benign Tumor
60%
Compound Analysis
50%
Headspace
50%
Polyamines
50%
Spectrometry Analysis
50%
Volatile Organic Compounds
50%
Pancreatic Cancer
50%
Diacetylspermine
40%
Urine Samples
36%
Benign Ovarian Tumor
30%
Healthy Controls
25%
Genital Prolapse
20%
Postmenopausal Women
20%
Liquid Chromatography-tandem Mass Spectrometry (LC-MS/MS)
20%
Malignancy
20%
Ovarian Tumor
20%
High-grade Cancer
20%
Advanced Stage
18%
Linear Discriminant Analysis
18%
Proof of Concept Study
18%
Olfactory System
10%
Artificial Olfactory System
10%
Early Cancer
10%
10-fold Cross Validation
10%
MS Method
10%
High-grade Ovarian Cancer
10%
Canine
10%
Morning Urine
10%
Carbohydrate Antigen 125 (CA125)
10%
Before Surgery
10%
Serum CA125
10%
Standardized Analysis
10%
Cancer Stage
10%
Low Malignant Potential Tumor
10%
Adnexal Mass
10%
Low Malignant Potential
10%
Urinary Incontinence
10%
Differential Diagnostics
10%
Malignant Tumor
10%
I to
10%
Detection Method
10%
Tumor
10%
Elevated Concentrations
10%
Quadratic Data
10%
Low-grade Tumor
10%
Leave-one-out
8%
Delayed Diagnosis
8%
Medicine and Dentistry
Ovarian Cancer
100%
Field Asymmetric Waveform Ion Mobility Spectrometry
91%
Ovarian Tumor
90%
Benign Tumor
60%
Polyamine
50%
Biological Marker
50%
Pancreas Cancer
50%
Volatile Organic Compound
50%
Urinary System
50%
Urine Sampling
36%
Neoplasm
30%
Cancer
30%
Liquid Chromatography-Mass Spectrometry
30%
Malignant Neoplasm
20%
Postmenopause
20%
Cancer Grading
20%
CA-125
20%
Pelvic Organ Prolapse
20%
Cross-Validation
18%
Discriminant Analysis
18%
Stage 1 Cancer
10%
Tandem Mass Spectrometry
10%
Diagnosis
10%
Prospective Study
10%
Olfactory System
10%
Adnexal Mass
10%
Urine Incontinence
10%
Enuresis
10%
Chronic Pancreatitis
8%
Urinalysis
8%
Acute Pancreatitis
8%
